Alan B. Miller, Executive Chairman of Universal Health Services (UHS), has demonstrated a clear selling bias in his recent insider transactions, with $128.6 million in total sales compared to $96 million in purchases across 37 reported trades. His activity has been concentrated in two healthcare-related securities: UHS and Universal Health Realty Income Trust (UHT). The most significant transactions occurred in March 2026, when Miller sold $21.7 million worth of UHS shares on March 10 through open market dispositions (Code M) and an additional $24.8 million in derivative transactions (Code F) on March 12. This followed a similar pattern from October 2025, when he executed derivative transactions worth $23.9 million in UHS alongside a smaller $453,404 sale of UHT shares.
While Miller’s trading history includes occasional acquisitions—such as a $218,710 derivative transaction on March 21, 2026—the overwhelming trend has been toward divestment. Notably, many of the sales appear structured, with multiple transactions on single dates, such as the March 10, 2026, sales totaling $30.9 million across different execution methods. The absence of recent buys beyond minor derivative adjustments suggests a continued reduction in exposure to UHS, though the zero-dollar transactions (Code A and J) indicate some non-monetary adjustments to holdings, likely related to equity awards or transfers. The consistency of sales across both open market and derivative dispositions points to a deliberate, multi-year unwinding of positions rather than short-term portfolio rebalancing.
AI-assisted summary